AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022.
Arbeitsgemeinschaft Gynäkologische Onkologie
Diagnosis
Metastatic breast cancer
Recommendations
Treatment
Journal
Breast care (Basel, Switzerland)
ISSN: 1661-3791
Titre abrégé: Breast Care (Basel)
Pays: Switzerland
ID NLM: 101254060
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
17
04
2022
accepted:
21
04
2022
entrez:
26
9
2022
pubmed:
27
9
2022
medline:
27
9
2022
Statut:
ppublish
Résumé
The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) presents the 2022 update of the evidence-based recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer.
Identifiants
pubmed: 36156913
doi: 10.1159/000524789
pii: brc-0017-0421
pmc: PMC9453659
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
421-429Informations de copyright
Copyright © 2022 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
Prof. Dr. Med. Marc Thill. Advisory boards: Agendia, Amgen, AstraZeneca, Aurikamed, Becton and Dickinson, ClearCut, Clovis, Daiichi Sankyo, Eisai, Exact Sciences, Gilead Science, Grünenthal, GSK, Lilly, MSD, Neodynamics, Novartis, Onkowissen, Organon, Pfizer, pfm Medical, Pierre-Fabre, Roche, Seagen, Sirius Pintuition, Sysmex. Manuscript support: Amgen, Clearcut, Clovis, pfm medical, Roche, Servier. Travel reimbursement: Amgen, art tempi, AstraZeneca, Clovis, Connect Medica, Daiichi Sankyo, Eisai, Exact Sciences, Lilly, MSD, Novartis, Pfizer, pfm Medical, Roche, Seagen. Congress support: Amgen, AstraZeneca, Daiichi Sanyko, Novartis, Pfizer, Roche. Lecture: Amgen, art tempi, AstraZeneca, Clovis, Connect Medica, Daiichi Sankyo, Exact Sciences, Gilead Science, Hexal, I-Med-Institute, Jörg Eickeler, Lilly, MSD, Novartis, Onkowissen, Pfizer, pfm medical, Roche, Seagen, Sysmex, Vifor, Viatris. Trial funding: Endomagnetics, Exact Sciences. Prof. Dr. Med. Diana Lüftner. Advisory board: AstraZeneca, Eli Lilly, GSK, Novartis, Onkowissen, High5MD, Loreal, Pfizer, Roche, TEVA, Gilead Science. Lecture: AstraZeneca, Eli Lilly, GSK, Novartis, Onkowissen, High5MD, Loreal, Pfizer, Roche, TEVA, Gilead Science. Prof. Dr. Med. Cornelia Kolberg-Liedtke. Advisory board: Aurikamed, Novartis, Pfizer, MSD, Novartis, Gilead Science, Seagen, Lilly, Agendia, Daiichi Sankyo. Lecture: Roche, Novartis, Pfizer, Exact Sciences, Amgen, AstraZeneca, Carl Zeiss Meditec, NCO Hannover. Other: Gilead Science, POMME. Stockholding: Phaon Scientific. Trial Funding: Gilead Science. Prof. Dr. Med. Ute-Susann Albert. Lectures and/or consulting: Pfizer, Novartis, Aurikamed. PD Dr. Malgorzata Banys-Paluchowski. Advisory board: Novartis, Roche, LIlly, Pfizer, GSK, MSD. Lecture: Novartis, Pfizer, pfm medical, Seagen, Daiichi Sankyo, Lilly, Roche, Amgen. Trial funding: Mammotome, Exact Sciences, Merit Medical, Endomag. Dr. Med. Ingo Bauerfeind. No conflicts of interest. Prof. Dr. Med. Jens-Uwe Blohmer. Honoraria: Astrazeneca, Eisai, Lilly, MSD, Novartis, Pfizer, Roche, Seagen. Prof. Dr. Med. Wilfried Budach. Lecture: Merck, medpublico GmbH, BVDST. Prof. Dr. Med. Peter Dall. Advisory Boards: Gilead Science, Roche. Lecture: Novartis, AstraZeneca, Pfizer. PD Dr. Med. Eva Maria Fallenberg. No conflicts of interest. Prof. Dr. Med. Peter A. Fasching. Advisory board: Pfizer, Novartis, Roche, Daiichi Sankyo, Eisai, AstraZeneca, Lilly, MSD, Seagen, Agendia, Pierre Fabre, Sanofi Aventis, Gilead Science. Lecture: Pfizer, Novartis, Roche, Daiichi Sankyo, Eisai, AstraZeneca, Lilly, MSD, Seagen, Gilead Science. Other: Onkowissen, art tempi. Prof. Dr. Med. Tanja N. Fehm. Onkowissen. Prof. Dr. Med. Michael Friedrich. Advisory Board: Gilead Science. Other honoraria: Roche, MSD. Stockholding: Biontech, Curevac. Prof. Dr. Med. Bernd Gerber. Lecture honoraria: Roche, AstraZeneca, Seagen, Novartis, Pfizer, MedConcept. Others: Pfizer. PD Dr. Med. Oleg Gluz. No conflicts of interest. Prof. Dr. Med. Nadia Harbeck. Honoraria for lectures and/or consulting: Amgen, AstraZeneca, Daiichi Sanyko, Gilead Science, Lilly, MSD, Novartis, Pierre-Fabre, Pfizer, Roche, Sandoz, Seagen, Exact Sciences. Minority shareholder: Westdeutsche Studiengruppe (WSG). Prof. Dr. Med. Jörg Heil. Advisory board: Polytech. Trial funding: pfm medical. Prof. Dr. Med. Jens Huober. Lecture: Gilead Science, Seagen, Lilly, Novartis, Daiichi Sankyo, GSK, Pfizer. Prof. Dr. Med. Christian Jackisch. Advisory board: Exact Sciences, Pfizer, Roche, GSK, Pierre-Fabre. Lecture: AstraZeneca, Lilly, Novartis. Prof. Dr. Med. Hans-Heinrich Kreipe. Advisory board: Lilly. Lecture: AstraZeneca, Roche, Daiichi Sankyo, Pfizer. Dr. David Krug. Lecture: MSD, ESO, ESMO, medupdate GmbH. Trial funding: Merck. Prof. Dr.med. Thorsten Kühn. Advisory Board: Sysmex, Neodynamics. Trial funding: Merit Medical, Endomag, Mammotome. Lecture: Pfizer. Prof. Dr. Med. Sherko Kümmel. Lecture: Roche, Lilly, Exact Sciences, Novartis, Amgen, Daiichi Sankyo, AstraZeneca, Somatex, MSD, Pfizer, pfm medical, Seagen, Gilead Science, Agendia. Other honoraria: Roche, Daiichi Sankyo, Sonoscape Advisory board: Lilly, MSD, Roche. Prof. Dr. Med. Sibylle Loibl. Trial funding: Abbvie, AstraZeneca, Celgene, Daiichi Sankyo, Gilead Science, Novartis, Pfizer, Roche. Lecture: Abbvie, Amgen, AstraZeneca, Bayer, BMS, Celgene, Daiichi Sankyo, Eirgenix, GSK, Gilead Science, Lilly, Merck, Novartis, Pfizer, Pierre Fabre, Prime/Medscape, Puma, Roche, Samsung. Prof. Dr. Med. Michael Patrick Lux. Lecture: Lilly, Roche, MSD, Onkowissen, Novartis, Pfizer, Exact Sciences, Daiichi Sankyo, Gilead, Grünenthal, Eisai, AstraZeneca. Advisory board: pfm medical, Saman Tree, Sysmex, Lilly, AstraZeneca, MSD, Novartis, Pfizer, Eisai, Gilead, Exact Sciences, Daiichi Sankyo, Grünenthal, Pierre Fabre, PharmaMar, Roche. Other: Medac, Pfizer. Prof. Dr. Med. Nicolai Maass. Advisory board: Amgen, Grünenthal. Lecture: AstraZeneca, Pierre Fabre, Clovis, Seagen, Lilly, MSD, Novartis, Pfizer. Prof. Dr. Med. Christoph Mundhenke. Not specified. Prof. Dr. Med. Ulrike Nitz. Not specified. Prof. Dr. Tjoung-Won Park-Simon. Advisory board: Roche, AstraZeneca, GSK, Pfizer, Lilly, MSD, Exact Sciences, Daiichi Sankyo, Seagen, Novartis, Gilead Science. Lecture: Roche, AstraZeneca, GSK, Pfizer, Lilly, MSD, NCO, Exact Sciences, Daiichi Sankyo, Seagen, Novartis, Gilead Science. Prof. Dr. Med. Toralf Reimer. Trial funding: Novartis, German Cancer Aid and Else Kroener-Fresenius-Stiftung. Advisory board: MSD, Novartis, Myriad. Lecture: Pfizer, Novartis, Roche, AstraZeneca. PD. Dr. Med. Kerstin Rhiem. Lecture: AstraZeneca, Amgen, MDS, Medupdate, Medconcept. Prof. Dr. Med. Achim Rody. Advisory board: AstraZeneca, Novartis, Roche, Exact Sciences, Pierre Fabre, Lilly, Seagen, Amgen, MSD. Lecture: Pfizer, Celgene, Eisai. Trial funding: Eisai. Prof. Dr. Med. Marcus Schmidt. Advisory board: AstraZeneca, Novartis, Eisai, Lilly, MSD, Pierre Fabre, Pfizer, Roche, Seagen. Prof. Dr. Med. Andreas Schneeweiss. Lecture: Amgen, AstraZeneca, Aurikamed, Clinsol, ConnectMedica, Gilead Science, GSK, I-Med, Lilly, MSD, Nanostring, Novartis, Onkowissen, Promedicis, Pfizer, Pierre Fabre, Roche, Seagen, StreamedUp. Other: Thieme. Prof. Dr. Med. Florian Schütz. Lecture: Amgen, AstraZeneca, Eisai, Pfizer, Novartis, Onkowissen. Advisory board: Amgen, Lilly, MSD, Eisai. Prof. Dr. Med. Hans-Peter Sinn. Advisory board: Diaceutics. Prof. Dr. Med. Christine Solbach. Lecture: DiaLog Service GmbH, Jörg Eickeler, Pfizer, MedConcept, Medicultus, GBG, Dt. Röntgengesellschaft, BVF Akademie, LÄK Hessen Akademie, Meet the Expert Academy. Advisory board: MSD, Roche. Prof. Dr. Med. Erich-Franz Solomayer. Lecture: Universitätsklinikum Freiburg, MedConcept, Saarländische Krebsgesellschaft, Bsh medical Communications GmbH, Pfizer, AstraZeneca. Other: Roche, Amgen, Clovis, AstraZeneca, Novartis, GSK, MSD, Eisai, Pfizer, Medac, Pierre Fabre, PharmaMar, Daiichi Sankyo, Samsung, Primus, matramed, GE Healthcare. Trial funding: Medac, GBG, AMS, AstraZeneca, Pfizer, Novartis, AGO Research GmbH, WSG, Universitätsklinikum Tübingen, Roche. Prof. Dr. Med. Elmar Stickeler. Advisory boards: Gilead, Iomedico, Lilly, MSD, Seagen. Lecture: Pfizer, Bsh Düsseldorf, Gilead, Iomedico, PharmaMar, Onkowissen, Roche. Prof. Dr. Med. Christoph Thomssen. Advisory board: Amgen, AstraZeneca, Hexal, Lilly, MSD, Pfizer, Roche, Seagen. Lecture: Klnikum Wolfsburg, Medicultus, Medupdate, Novartis, Pfizer, Roche, AstraZeneca, Daiichi Sankyo, Jörg Eickeler, Evang. KH Wittenberg, Gilead Science. Other: Aurikamed, ForumSanitas/Merit Corporate, Onkowissen, Pfizer, Daiichi Sankyo. Prof. Dr. Med. Michael Untch. Advisory board: Lilly, AstraZeneca, Pfizer, Roche, Pierre Fabre, Sanofi Aventis, Gilead Science. Lecture: Daiichi Sankyo, Lilly, Seagen, Novartis, AstraZeneca, Roche, Eisai, MSD, I-Med_Insitute, Onkowissen, art tempi, High5Med. Prof. Dr. Isabell Witzel. Lecture: Daiichi Sankyo, Pfizer, MSD, Lilly, Seagen, AstraZeneca. Other: Onkowissen Prof. Dr. Med. Achim Wöckel. Advisory board: Amgen, AstraZeneca, Aurikamed, Celgene, Eisai, Lilly, Novartis, Pfizer, Roche, Tesaro, Sirtex, MSD, Genomic Health, Pierre Fabre, Clovis, Organon. Prof. Dr. Med. Volkmar Müller. Lecture: Amgen, AstraZeneca, Daiichi Sankyo, eisai, GSK, Pfizer, MSD, Medac, Novartis, Roche, Teva, Seagen, Onkowissen, High5Oncology, Medscape, Gilead. Advisory board: Hexal, Roche, Pierre Fabre, Amgen, Clinsol, Novartis, MSD, Daiichi Sankyo, Eisai, Lilly, Sanofi Aventis, Seagen, Gilead Science. Trial funding: Novartis, Roche, Seagen, Genetech. Other: Daiichi Sankyo. Prof. Dr. Med. Wolfgang Janni. Lecture: Amgen, AstraZeneca, Daiichi Sankyo, Lilly, MSD, Novartis, Pfizer, Roche, Seagen, Gilead Science. Trial Funding: Amgen, AstraZeneca, Lilly, Novartis, Roche. Prof. Dr. Med. Nina Ditsch. Not specified.
Références
N Engl J Med. 2020 Feb 13;382(7):610-621
pubmed: 31825192
Clin Spine Surg. 2017 May;30(4):156-163
pubmed: 28437329
Breast. 2013 Jun;22(3):203-10
pubmed: 23601761
N Engl J Med. 2022 Mar 10;386(10):942-950
pubmed: 35263519
Neuro Oncol. 2021 Jun 1;23(6):894-904
pubmed: 33367836
BMC Cancer. 2020 May 6;20(1):392
pubmed: 32375735
Ann Surg Oncol. 2021 Sep;28(9):5048-5057
pubmed: 33532878
J Clin Oncol. 2020 Dec 20;38(36):4274-4282
pubmed: 33119476
Ann Oncol. 2021 Aug;32(8):994-1004
pubmed: 34219000
Cochrane Database Syst Rev. 2021 Apr 22;4:CD011395
pubmed: 33886122
Support Care Cancer. 2021 May;29(5):2305-2317
pubmed: 33190182
N Engl J Med. 2019 May 16;380(20):1929-1940
pubmed: 31091374
J Clin Oncol. 2016 Sep 1;34(25):2961-8
pubmed: 27269946
N Engl J Med. 2019 Jul 25;381(4):307-316
pubmed: 31166679
Lancet Oncol. 2020 Jan;21(1):44-59
pubmed: 31786121
Ann Oncol. 2021 Nov;32(11):1332-1347
pubmed: 34364998
Crit Rev Oncol Hematol. 2019 May;137:1-8
pubmed: 31014505
J Clin Oncol. 2020 Nov 1;38(31):3698-3715
pubmed: 32716741
Oncologist. 2021 Dec;26(12):1008-1016
pubmed: 34506675
Ann Oncol. 2020 Nov;31(11):1491-1505
pubmed: 32853681
N Engl J Med. 2022 Mar 24;386(12):1143-1154
pubmed: 35320644
J Clin Oncol. 2020 Aug 10;38(23):2610-2619
pubmed: 32468955
Ann Surg Oncol. 2021 Oct;28(10):5544-5552
pubmed: 34287787
J Am Coll Surg. 2021 Dec;233(6):742-751.e5
pubmed: 34530124
Ann Oncol. 2020 Dec;31(12):1623-1649
pubmed: 32979513
Ann Surg Oncol. 2020 Oct;27(11):4488-4499
pubmed: 32436193
Lancet Oncol. 2020 Jun;21(6):763-775
pubmed: 32353342
Nature. 2018 Feb 8;554(7691):189-194
pubmed: 29420467
Ann Oncol. 2020 Sep;31(9):1223-1230
pubmed: 32464281
Lancet Oncol. 2014 Apr;15(4):406-14
pubmed: 24636208
N Engl J Med. 2020 Feb 13;382(7):597-609
pubmed: 31825569
Lancet Oncol. 2015 Oct;16(13):1380-8
pubmed: 26363985
Nat Rev Clin Oncol. 2018 Dec;15(12):731-747
pubmed: 30333516
Breast Cancer Res Treat. 2021 Feb;186(1):219-227
pubmed: 33150548
N Engl J Med. 2021 Apr 22;384(16):1529-1541
pubmed: 33882206
Eur J Cancer. 2021 Jan;142:132-140
pubmed: 33023785
Ann Surg. 2019 Jun;269(6):1163-1169
pubmed: 31082916
J Oncol Pract. 2017 Feb;13(2):119-121
pubmed: 28972832